Instadose Pharma Corp. (INSD)

USD 0.0

(0.0%)

Total Liabilities Summary of Instadose Pharma Corp.

Instadose Pharma Corp.'s latest annual total liabilities in 2023 was - USD , down -100.0% from previous year.
Instadose Pharma Corp.'s latest quarterly total liabilities in 2024 Q1 was - USD , down 0.0% from previous quarter.
Instadose Pharma Corp. reported annual total liabilities of 206.79 Thousand USD in 2022, down 0.0% from previous year.
Instadose Pharma Corp. reported annual total liabilities of 206.79 Thousand USD in 2021, up 93.23% from previous year.
Instadose Pharma Corp. reported quarterly total liabilities of - USD for 2023 Q4, down 0.0% from previous quarter.
Instadose Pharma Corp. reported quarterly total liabilities of - USD for 2023 Q2, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Instadose Pharma Corp. (2023 - 2017)

Historical Annual Total Liabilities of Instadose Pharma Corp. (2023 - 2017)

Year	Total Liabilities	Total Liabilities Growth
2023	- USD	-100.0%
2022	206.79 Thousand USD	0.0%
2021	206.79 Thousand USD	93.23%
2020	107.02 Thousand USD	140.4%
2019	44.51 Thousand USD	163.71%
2018	16.88 Thousand USD	540.72%
2017	2634.68 USD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	- USD	0.0%
2023 Q4	- USD	0.0%
2023 Q2	- USD	0.0%
2023 Q3	- USD	0.0%
2023 FY	- USD	-100.0%
2023 Q1	- USD	0.0%
2022 Q3	10.28 Million USD	4871.97%
2022 FY	206.79 Thousand USD	0.0%
2022 Q1	142.8 Thousand USD	95.71%
2022 Q2	206.79 Thousand USD	44.81%
2021 FY	206.79 Thousand USD	93.23%
2021 Q4	72.97 Thousand USD	358.99%
2021 Q1	97.52 Thousand USD	-0.18%
2021 Q3	15.89 Thousand USD	-85.14%
2021 Q2	107.02 Thousand USD	9.74%
2020 Q4	97.69 Thousand USD	10.99%
2020 FY	107.02 Thousand USD	140.4%
2020 Q3	88.01 Thousand USD	16.81%
2020 Q2	75.34 Thousand USD	7.87%
2020 Q1	69.85 Thousand USD	9.14%
2019 Q3	56.12 Thousand USD	26.08%
2019 Q2	44.51 Thousand USD	13.76%
2019 Q1	39.13 Thousand USD	14.89%
2019 FY	44.51 Thousand USD	163.71%
2019 Q4	64 Thousand USD	14.03%
2018 Q4	34.06 Thousand USD	2.58%
2018 Q2	16.88 Thousand USD	52.05%
2018 Q3	33.2 Thousand USD	96.68%
2018 Q1	11.1 Thousand USD	66.65%
2018 FY	16.88 Thousand USD	540.72%
2017 FY	2634.68 USD	0.0%
2017 Q4	6661.81 USD	0.0%

Peer Total Liabilities Comparison of Instadose Pharma Corp.

Name	Total Liabilities	Total Liabilities Difference
BioQuest Corp.	632.89 Thousand USD	100.0%
GSRX Industries Inc.	- USD	NaN%
High Sierra Technologies, Inc.	611.78 Thousand USD	100.0%